Pleural tuberculosis

Tuberculous pleural effusions occur in up to 30% of patients with tuberculosis. It appears that the percentage of patients with pleural effusion is comparable in human immunodeficiency virus (HIV)-positive and HIV-negative individuals, although there is some evidence that HIV-positive patients with CD4+ counts <200 cells x mL(-1) are less likely to have a tuberculous pleural effusion. There has recently been a considerable amount of research dealing with the immunology of tuberculous pleurisy. At present, we have more evidence that activated cells produce cytokines in a complex pleural response to mycobacteria. Intramacrophage elimination of mycobacterial antigens, granuloma formation, direct neutralization of mycobacteria and fibrosis are the main facets of this reaction. With respect to diagnosis, adenosine deaminase and interferon gamma in pleural fluid have proved to be useful tests. Detection of mycobacterial deoxyribonucleic acid (DNA) by the polymerase chain reaction is an interesting test, but its usefulness in the diagnosis of tuberculous pleurisy needs further confirmation. The recommended treatment for tuberculous pleurisy is a 6 month regimen of isoniazid and rifampicin, with the addition of pyrazinamide in the first 2 months. HIV patients may require a longer treatment. The general use of corticosteroids is not recommended at this time, but they can be used in individuals who are markedly symptomatic.

This article has been cited by other articles:

				Z. D. Daniil, E. Zintzaras, T. Kiropoulos, A. I. Papaioannou, A. Koutsokera, A. Kastanis, and K. I. Gourgoulianis Discrimination of exudative pleural effusions based on multiple biological parameters Eur. Respir. J., November 1, 2007; 30(5): 957 - 964. [Abstract] [Full Text] [PDF]

				A. Gopi, S. M. Madhavan, S. K. Sharma, and S. A. Sahn Diagnosis and Treatment of Tuberculous Pleural Effusion in 2006 Chest, March 1, 2007; 131(3): 880 - 889. [Abstract] [Full Text] [PDF]

				H. Reuter, L. Burgess, W. van Vuuren, and A. Doubell Diagnosing tuberculous pericarditis. QJM, December 1, 2006; 99(12): 827 - 839. [Abstract] [Full Text] [PDF]

				C. H. Doerr, M. S. Allen, F. C. Nichols III, and J. H. Ryu Etiology of Chylothorax in 203 Patients Mayo Clin. Proc., July 1, 2005; 80(7): 867 - 870. [Abstract] [PDF]

				H S A Roberts, R J O Davies, C W H Davies, and F V Gleeson BTS guidelines for the management of pleural infection * Authors' reply Thorax, February 1, 2004; 59(2): 178 - 178. [Full Text] [PDF]

				N. A. Hasaneen, M. E. Zaki, H. M. Shalaby, and A. S. El-Morsi Polymerase Chain Reaction of Pleural Biopsy Is a Rapid and Sensitive Method for the Diagnosis of Tuberculous Pleural Effusion Chest, December 1, 2003; 124(6): 2105 - 2111. [Abstract] [Full Text] [PDF]

				M. B. Conde, A. C. Loivos, V. M. Rezende, S. L. M. Soares, F. C. Q. Mello, A. L. Reingold, C. L. Daley, and A. L. Kritski Yield of Sputum Induction in the Diagnosis of Pleural Tuberculosis Am. J. Respir. Crit. Care Med., March 1, 2003; 167(5): 723 - 725. [Abstract] [Full Text] [PDF]

				K. M. Al-Kattan Management of tuberculous empyema Eur. J. Cardiothorac. Surg., March 1, 2000; 17(3): 251 - 254. [Abstract] [Full Text] [PDF]

				L. Valdes, D. Alvarez, E. San Jose, P. Penela, J. M. Valle, J. M. Garcia-Pazos, J. Suarez, and A. Pose Tuberculous Pleurisy: A Study of 254 Patients Arch Intern Med, October 12, 1998; 158(18): 2017 - 2021. [Abstract] [Full Text] [PDF]